Modification of cardiac disease by transgenically altered histone deacetylase 6

Histone deacetylase 6 (HDAC6) is known to deacetylate amino acid lysine in alpha-tubulin. However, the functional role of HDAC6 in the progression of cardiac disease remains uncertain. The functional role of HDAC6 in the hearts was examined using transgenic (TG) mice expressing either human wild-typ...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2022-11, Vol.631, p.48-54
Main Authors: Sanbe, Atsushi, Inomata, Yui, Matsushita, Naoko, Sawa, Yohei, Hino, Chizuru, Yamazaki, Hinano, Takanohashi, Kei, Takahashi, Natsuko, Higashio, Rieko, Tsumura, Hideki, Aoyagi, Toshinori, Hirose, Masamichi
Format: Article
Language:English
Subjects:
Acetylation
Animals
Aspartic Acid - metabolism
Cortactin - metabolism
HDAC6
Heart Diseases
Heart failure
Histone Deacetylase 6 - genetics
Histone Deacetylase 6 - metabolism
Histone Deacetylases - genetics
Histone Deacetylases - metabolism
Humans
Hypertrophy
Isoproterenol
Lysine - metabolism
Mice
Mice, Transgenic
Serine - metabolism
Threonine - metabolism
Transgenic mouse
Tubulin - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Histone deacetylase 6 (HDAC6) is known to deacetylate amino acid lysine in alpha-tubulin. However, the functional role of HDAC6 in the progression of cardiac disease remains uncertain. The functional role of HDAC6 in the hearts was examined using transgenic (TG) mice expressing either human wild-type HDAC6, deacetylase inactive HDAC6 (HDAC6H216A, H611A), and human HDAC6 replaced all serine or threonine residues with aspartic acid at N-terminal 1- 43 amino acids (HDAC6NT-allD) specifically in the hearts. Overexpression of wild-type HDAC6 significantly reduced acetylated tubulin levels, and overexpression of HDAC6H216A, H611A significantly increased it in the mouse hearts. Detectable acetylated tubulin disappeared in HDAC6NT-allD TG mouse hearts. Neither histological alteration nor alteration of cardiac function was observed in the HDAC6 TG mouse hearts. To analyze the role of HDAC6 and acetylated tubulin in disease conditions, we examined HDAC6 in isoprenaline-induced hypertrophy or pressure-overload hypertrophy (TAC). No obvious alteration in the heart weight/body weight ratio or gene expressions of hypertrophic markers between NTG and HDAC6NT-allD mice was observed following treatment with isoprenaline. In contrast, a marked reduction in the shortening fraction and dilated chamber dilatation was detected in the HDAC6NT-allD TG mouse hearts 2 weeks after TAC. A sustained low level of acetylated tubulin and acetylated cortactin was observed in the TAC HDAC6NT-allD TG mouse hearts. Cardiac HDAC6 activity that can regulate acetylated levels of tubulin and cortactin may be critical factors involved in cardiac disease such as pressure-overload hypertrophy. •Marked disease progression can be induced by pressure overload in hearts with high HDAC6 activity.•No alteration in cardiac phenotypes against adrenergic β-adrenoceptor stimulation was observed in high HDAC6 activity mice.•Overexpression of inactive HDAC6 can prevent disease progression against pressure overload.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2022.09.055